Rituxan SC (rituximab)

pCPA File Number: 20893
Negotiation Status:
Concluded with an LOI
Indication(s):
Acute Lymphoblastic Leukemia (ALL)
Sponsor/Manufacturer:
Hoffmann-La Roche Ltd.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: